Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solid Biosciences Inc. Director's Dealing 2018

Jan 26, 2018

33003_dirs_2018-01-25_b28e7de5-9602-41cf-97e3-7617dce78d21.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Solid Biosciences, LLC (SLDB)
CIK: 0001707502
Period of Report: 2018-01-25

Reporting Person: Hayeem Gilad David (Director, President, 10% Owner)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1984644 Direct
Common Stock 1593755 Indirect

Footnotes

F1: Shares held by The Popps Trust, a trust established for the benefit of Mr. Hayeem's family for which Mr. Hayeem is the Investment Adviser.